Nucleic Acid Purification Using Chaotropic Elution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anion exchange chromatographic methods for nucleic acid purification face challenges in recovering nucleic acids from anion exchange resins, particularly for longer chain nucleic acids, with conventional methods achieving only 20-50% recovery due to strong interactions between nucleic acids and ion exchange resins, and using sodium hydroxide for elution risking denaturation and degradation.
Innovation Solution
The method involves using an elution solution with high salt concentration and an additive that increases the pH to between 9 and 13, such as guanidine or potassium carbonate, to enhance nucleic acid recovery from anion exchange resins without impairing stability, allowing for 70-95% recovery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional anion exchange chromatography is used to purify nucleic acids, then separation from contaminants is achieved, but nucleic acid recovery is poor (20-50%) due to strong binding interactions
Solution Approach 1:
The patent applies parameter changes by modifying the chemical composition and pH of the elution buffer. Specifically, it uses buffers with pH 8.0-9.5 containing chaotropic agents (guanidine HCl, guanidine SCN, guanidine SO4, thiocyanate, perchlorate, iodide, bromide) at optimized concentrations to disrupt the strong electrostatic interactions between nucleic acids and the anion exchange resin, enabling efficient elution with 70-95% recovery while maintaining nucleic acid integrity
Solution Approach 2:
The patent introduces chaotropic agents as intermediary substances that mediate the elution process. These agents act as competitors for binding sites on the resin and disrupt the nucleic acid-resin complex, facilitating the release of bound nucleic acids into the eluate without causing denaturation or degradation
2Reliability
If sodium hydroxide is used for elution to overcome strong binding, then recovery improves, but nucleic acid stability is compromised due to denaturation and degradation
Solution Approach 1:
The patent changes the pH parameter from highly alkaline (NaOH, pH >12) to a milder range (pH 8.0-9.5) while compensating with chaotropic agents that provide the necessary binding disruption. This parameter optimization maintains nucleic acid stability while achieving high recovery rates, avoiding the denaturation and degradation problems associated with strong bases
Solution Approach 2:
The patent achieves the elution effect of strong bases (like NaOH) without using them directly, by copying the functional outcome through alternative chemical means - using chaotropic agents at controlled pH that provide similar binding disruption while preserving nucleic acid integrity
3Reliability
If resin equilibration step is included in the protocol, then binding efficiency is improved, but process complexity and time increase
Solution Approach 1:
The patent extracts or removes the separate resin equilibration step from the traditional protocol. By formulating the loading buffer to contain chaotropic agents and optimized salt concentrations, the buffer itself performs the equilibration function, eliminating the need for a separate equilibration step while maintaining binding efficiency and reducing process complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly improves nucleic acid recovery from anion exchange resins while maintaining stability, with the use of alkaline pH and specific additives like guanidine or arginine optimizing desorption kinetics and reducing the need for resin equilibration steps.
Implementation Method 1
contacting the aqueous solution containing the nucleic acid with an anion exchanger bound to a solid support matrix under conditions such that the anion exchanger binds the nucleic acid
Implementation Method 2
eluting the anion exchanger with an aqueous mobile phase comprising a nucleic acid elution salt solution wherein the elution solution comprises an additive such that the pH of the aqueous mobile phase is between about pH 9 and about pH 13
Implementation Method 3
the presence of the additive in the elution solution provides an increase in the nucleic acid recovery from the anion exchanger
Data Source
AI summary
The invention provides an improved method for the purification of nucleic acid molecules, which method comprises generating a cellular lysate containing the nucleic acid; contacting the lysate with an anion exchanger bound to a solid support matrix under conditions such that the anion exchanger binds the nucleic acid; followed by eluting the nucleic acid from the anion exchanger with an aqueous mobile phase comprising an elution solution; and desalting the eluted nucleic acid such that it is suitable for downstream applications. The improvement of the method includes providing the anion exchanger in a packed column, wherein the column is packed using a salt solution containing an antimicrobial agent. In addition, the salt solution has a salt concentration similar to that of the lysate, such that the column does not need equilibration prior to sample loading.